Last reviewed 2026-04-20 · How we verify

Clobetasol Propionate 0.05% Emollient Foam

Callender Center for Clinical Research · FDA-approved active Small molecule Quality 0/100

Clobetasol Propionate 0.05% Emollient Foam is a Small molecule drug developed by Callender Center for Clinical Research. It is currently FDA-approved. Also known as: Olux-E.

Clobetasol Propionate 0.05% Emollient Foam, marketed by Callender Center for Clinical Research, is a topical corticosteroid with a key composition patent expiring in 2028. The drug's key strength lies in its emollient foam formulation, which may offer improved patient compliance and efficacy. The primary risk is the patent expiry in 2028, which could lead to increased competition from generic formulations.

At a glance

Generic name	Clobetasol Propionate 0.05% Emollient Foam
Also known as	Olux-E
Sponsor	Callender Center for Clinical Research
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in Alopecia (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Clobetasol Propionate 0.05% Emollient Foam CI brief — competitive landscape report
Clobetasol Propionate 0.05% Emollient Foam updates RSS · CI watch RSS
Callender Center for Clinical Research portfolio CI

Frequently asked questions about Clobetasol Propionate 0.05% Emollient Foam

What is Clobetasol Propionate 0.05% Emollient Foam?

Clobetasol Propionate 0.05% Emollient Foam is a Small molecule drug developed by Callender Center for Clinical Research.

Who makes Clobetasol Propionate 0.05% Emollient Foam?

Clobetasol Propionate 0.05% Emollient Foam is developed and marketed by Callender Center for Clinical Research (see full Callender Center for Clinical Research pipeline at /company/callender-center-for-clinical-research).

Is Clobetasol Propionate 0.05% Emollient Foam also known as anything else?

Clobetasol Propionate 0.05% Emollient Foam is also known as Olux-E.

What development phase is Clobetasol Propionate 0.05% Emollient Foam in?

Clobetasol Propionate 0.05% Emollient Foam is FDA-approved (marketed).

Manufacturer: Callender Center for Clinical Research — full pipeline
Also known as: Olux-E
Compare: Clobetasol Propionate 0.05% Emollient Foam vs similar drugs
Pricing: Clobetasol Propionate 0.05% Emollient Foam cost, discount & access